Clinicopathological characters and prognostic significance of cytokeratins expression in intrahepatic cholangiocarcinoma.

被引:0
|
作者
Zhu, Q.
Yang, X.
Xu, Y.
Fan, J.
机构
[1] Zhong Shan Hosp, Liver Canc Inst, Shanghai, Peoples R China
[2] Shanghai Med Sch, Shanghai, Peoples R China
[3] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China
[4] Zhong Shan Hosp, Liver Canc Inst, Shanghai, Peoples R China
[5] Fudan Univ, Shanghai Med Sch, Shanghai 200433, Peoples R China
关键词
D O I
10.1200/jco.2011.29.15_suppl.e14667
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e14667
引用
收藏
页数:1
相关论文
共 50 条
  • [1] The clinicopathological and prognostic significance of alpha-fetoprotein expression in intrahepatic cholangiocarcinoma. A possible progenitor cell origin
    Soeda, Junpei
    Nakata, Takenari
    Miwa, Shiro
    Miyagawa, Shinichi
    [J]. HEPATOLOGY, 2007, 46 (04) : 419A - 419A
  • [2] Clinicopathological and prognostic significance of epithelial mesenchymal transition-related protein expression in intrahepatic cholangiocarcinoma
    Yao, Xing
    Wang, Xiang
    Wang, Zishu
    Dai, Licheng
    Zhang, Guolei
    Yan, Qiang
    Zhou, Weimin
    [J]. ONCOTARGETS AND THERAPY, 2012, 5 : 255 - 261
  • [3] Expression of keratin 20 and its clinicopathological significance in intrahepatic cholangiocarcinoma
    Choi, Ji Eun
    Noh, Sang Jae
    Lee, Ju Hyung
    Bae, Jun Sang
    Chu, Hyun Hee
    Park, Ho Sung
    Jang, Kyu Yun
    Chung, Myoung Ja
    Kang, Myoung Jae
    Lee, Dong Geun
    Moon, Woo Sung
    [J]. ONCOLOGY LETTERS, 2012, 4 (03) : 534 - 540
  • [4] Expression of cyclooxygenase-2 in intrahepatic cholangiocarcinoma.
    Jin, YM
    Joo, HJ
    Lee, KB
    Wang, HJ
    [J]. HEPATOLOGY, 1999, 30 (04) : 277A - 277A
  • [5] Clinicopathological and Prognostic Significance of Immunoscore and PD-L1 in Intrahepatic Cholangiocarcinoma
    Wu, Hong
    Wei, Yulong
    Jian, Mei
    Lu, Hong
    Song, Qingzhu
    Hao, Liheng
    Yue, Yong
    [J]. ONCOTARGETS AND THERAPY, 2021, 14 : 39 - 51
  • [6] Prognostic significance of NQO1 expression in intrahepatic cholangiocarcinoma
    Wakai, Toshifumi
    Shirai, Yoshio
    Sakata, Jun
    Matsuda, Yasunobu
    Korita, Pavel V.
    Takamura, Masaaki
    Ajioka, Yoichi
    Hatakeyama, Katsuyoshi
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2011, 4 (04): : 363 - 370
  • [7] Hepatolithiasis associated with intrahepatic cholangiocarcinoma.
    Sato, M
    Yamamoto, T
    Watanabe, Y
    Iseki, S
    Sato, N
    Kimura, S
    [J]. GASTROENTEROLOGY, 1996, 110 (04) : A1312 - A1312
  • [8] CA19-9 in intrahepatic cholangiocarcinoma. A diagnostic and prognostic armamentarium?
    Juntermanns, B.
    Kaiser, G. M.
    Gutierrez, S. Itani
    Heuer, M.
    Buechter, M.
    Kahraman, A.
    Reis, H.
    Kasper, S.
    Paul, A.
    Fingas, C. D.
    [J]. CHIRURG, 2018, 89 (06): : 466 - 471
  • [9] Immunohistochemical expression of cytokeratins in intrahepatic cholangiocarcinoma and metastatic adenocarcinoma of the liver
    Sasaki, A
    Kawano, K
    Aramaki, M
    Nakashima, K
    Yoshida, T
    Kitano, S
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 1999, 70 (02) : 103 - 108
  • [10] Clinicopathological significance of aberrant Notch receptors in intrahepatic cholangiocarcinoma
    Wu, Wen-Rui
    Shi, Xiang-De
    Zhang, Rui
    Zhu, Man-Sheng
    Xu, Lei-Bo
    Yu, Xian-Huan
    Zeng, Hong
    Wang, Jie
    Liu, Chao
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (06): : 3272 - 3279